Clinical trial registry record

To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together

A registered PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase 3 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated March 7, 2017.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT00318461
Last registry update
March 7, 2017
Status
Completed
Phase
Phase 3
Sponsor
Novo Nordisk A/S
Enrollment
1091
Countries
Argentina, Australia, Belgium, Bulgaria, Croatia, Denmark, Germany, Hungary, India, Ireland, Italy, Netherlands, Norway, Romania, Russia, Slovakia, South Africa, Spain, Sweden, United Kingdom
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE3 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 3
Study design
RANDOMIZED · PARALLEL · TREATMENT · DOUBLE
Evidence population
Human clinical study registration
Participants
1091
Population
ALL · 18 Years to 80 Years
Duration
2006-05-01 to 2008-11-01
Intervention
liraglutide; metformin; glimepiride; placebo
Comparator
Met Mono; Met + Glim
Outcomes measured
Change in Glycosylated A1c (HbA1c) at Week 26 — week 0, week 26; Change in Glycosylated A1c (HbA1c) at Week 104 — week 0, week 104; Change in Body Weight at Week 26 — week 0, week 26; Change in Body Weight at Week 104 — week 0, week 104; Change in Fasting Plasma Glucose (FPG) at Week 26 — week 0, week 26; Change in Fasting Plasma Glucose (FPG) at Week 104 — week 0, week 104; Change in Mean Prandial Increments of Plasma Glucose Based on Self-measured 7-point Plasma Glucose Profiles at Week 26…; Change in Mean Prandial Increments of Plasma Glucose Based on Self-measured 7-point Plasma Glucose Profiles at Week 104…; Change in Mean Post Prandial Plasma Glucose Based on Self-measured 7-point Plasma Glucose Profiles at Week 26 — week 0,…; Change in Mean Post Prandial Plasma Glucose Based on Self-measured 7-point Plasma Glucose Profiles at Week 104 — week 0…; Change in Beta-cell Function at Week 26 — week 0, week 26; Change in Beta-cell Function at Week 104 — week 0, week 104; Hypoglycaemic Episodes at Week 26 — weeks 0-26; Hypoglycaemic Episodes at Week 104 — weeks 0-104
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 3A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Metformin · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

metformin
Read the original source →Export JSON